Beijing Cancer Hospital
(Peking University Cancer Hospital)
A leading academic cancer center with 790 beds, specializing in advanced oncology treatments including CAR-T therapy, immunotherapy, and precision medicine.
Request Free ConsultationAbout Beijing Cancer Hospital
Peking University Cancer Hospital ranks among China's top academic cancer centers. Its physicians provide the highest quality of health care throughout the hospital, and its faculty members are respected for their dedication to teaching, training, and translational research.
The hospital provides patient-oriented medical services in a wide variety of cancer specialties including gastric cancer, breast cancer, lung cancer, colorectal cancer, liver cancer, esophageal carcinoma, lymphoma, melanoma, and much more. The team consists of experts from different disciplines including oncology, surgery, radiology, and pathology.
Key Highlights
- Member of National Clinical Pharmacology Base
- Over 700 clinical trials completed
- Advanced minimally invasive surgery techniques
- Multidisciplinary tumor boards for complex cases
- International accreditation and partnerships
- Integrated Traditional Chinese & Western Medicine
Team and Specialities
Comprehensive cancer care across all specialties
Medical Oncology
Advanced chemotherapy, targeted therapy, and immunotherapy protocols tailored to individual patient needs.
- Personalized treatment plans
- Immunotherapy coordination
- Clinical trial access
Surgical Oncology
Minimally invasive and advanced surgical techniques for tumor removal and reconstruction.
- Robotic surgery
- Laparoscopic procedures
- Organ preservation techniques
Radiotherapy
Advanced radiation therapy including IMRT, SBRT, and proton therapy for precise tumor targeting.
- Intensity Modulated Radiation Therapy
- Stereotactic Body Radiation Therapy
- Image-guided radiotherapy
CAR-T Cell Therapy
Advanced cellular immunotherapy for blood cancers and solid tumors with dedicated treatment units.
- Blood cancer CAR-T
- Solid tumor research
- Clinical trial participation
Hospital Infrastructure
State-of-the-art facilities for comprehensive cancer care
Beijing Cancer Hospital is one of the leading special hospitals in the field of cancer research and treatment in China. It has 790 hospital beds, 28 clinical departments and 13 medical technological departments.
Clinical Departments
Research & Clinical Trials
The hospital is a member of the national base for clinical pharmacology. Our hospital has completed over 700 clinical trials, including domestic clinical trials, international multi-center clinical trials, and clinical trials for medical equipment. There are ongoing programs across various cancer types and treatment modalities.
Location & Transportation
How to reach Beijing Cancer Hospital
Hospital Address
Beijing Cancer Hospital
52 Fucheng Road, Haidian District
Beijing, China 100142
+86-10-8819-6114
Interactive map available
for registered patients
Our coordination team provides detailed transportation instructions and can arrange airport pickup upon request.
Hospital Facilities & Services
Modern infrastructure and comprehensive patient services
Modern Facilities
State-of-the-art treatment rooms and patient care areas
Expert Medical Team
Specialized oncology doctors and nursing staff
Advanced Equipment
Cutting-edge diagnostic and treatment technology
Access Treatment at Beijing Cancer Hospital
Our medical tourism coordination service helps international patients access treatment at this premier cancer center
Submit Medical Records
Share your medical reports for preliminary review
Hospital Review
Beijing Cancer Hospital reviews your case
Treatment Proposal
Receive detailed treatment plan and cost estimate
Travel Coordination
We handle visas, accommodation, and logistics
Free Preliminary Consultation
Response within 48 hours · No commitment required · Medical coordination services free for patients
Need More Information?
Our medical tourism coordinators can provide detailed information about treatment options, costs, and logistics for Beijing Cancer Hospital.